Pharmaceutical Research and Manufacturers of America
Industry
Pharmaceuticals
Corporate Headquarters
Washington, D.C.
Corporate Profits, 2005-2024
N/A
Find an oligarch
Spending Snapshot
Campaign Spending
$147.8million
Lobbying Spending
$19.1million
Total Political Spending
$167.0million
Issues
- Spent $952K on a committee advancing the overall agenda of the California Chamber of Commerce
- Spent $952K on a committee advancing the overall agenda of the California Chamber of Commerce
- Spent $64.9 million to oppose Prop. 79 (Defeated, 2005), which would have reduced prescription drug prices
- Spent $56.9 million to support a competing ballot measure, Prop. 78 (Defeated, 2005), which would have made the drug discount program voluntary for pharmaceutical companies
- Spent $903K to oppose Prop. 61 (Defeated, 2016), which would have reduced prescription drug prices
- Lobbied against bills that sought to ensure the safety, effectiveness, and affordability of prescription drugs, including: AB-71 (Defeated, 2005-06), AB-75 (Defeated, 2005-06), SB-606 (Defeated, 2007-08), AB-2690 (Defeated, 2007-08), SB-1010 (Defeated, 2015-16), AB-463 (Defeated, 2015-16), SB-939 (Defeated, 2021-22)
- Spent $952K on a committee advancing the overall agenda of the California Chamber of Commerce
- Spent $5.6 million on “Citizens for Paycheck Protection,” a committee supporting the anti-union Prop. 75 (Defeated, 2005)
- Spent $952K on a committee advancing the overall agenda of the California Chamber of Commerce
- Spent $1.1 million to oppose Prop. 10 (2018), which would have expanded local governments’ authority to enact rent control measures
- Spent $952K on a committee advancing the overall agenda of the California Chamber of Commerce
- Spent $185K to oppose Prop. 15 (Defeated, 2020), which would have provided billions of dollars in new funding to schools
- Spent $952K on a committee advancing the overall agenda of the California Chamber of Commerce
- Spent $952K on a committee advancing the overall agenda of the California Chamber of Commerce
- Spent $335K to oppose Prop. 89 (Defeated, 2006), which would have established a public campaign finance program and limited other campaign contributions
- Lobbied against bills that sought to increase transparency around political spending, including: AB-919 (Defeated, 2009-10), SB-121 (Defeated, 2013-14)
- Spent $952K on a committee advancing the overall agenda of the California Chamber of Commerce
- Gave $270K to committees sponsored by the Civil Justice Association of California, which seeks to protect corporations from liability for the harm they cause
- Lobbied against SB-1489 (Vetoed, 2005-06), which was directed at ensuring that corporations could be held responsible for harm they cause
- Lobbied for bills aimed at making it more difficult to hold corporations responsible for harm they cause, including: AB-1905 (Defeated, 2007-08), AB-2740 (Defeated, 2009-10), AB-158 (Defeated, 2011-12)
- Spent $952K on a committee advancing the overall agenda of the California Chamber of Commerce
- Spent $952K on a committee advancing the overall agenda of the California Chamber of Commerce
- Spent $952K on a committee advancing the overall agenda of the California Chamber of Commerce
Republicans
$409.9k
Democrats
$960.3k
Total - All Current Elected Officials
$1.4million
Along with contributing directly to political campaigns and other efforts to support particular candidates, California’s top oligarchs and their allies make significant donations to other political action committees (PACs). These PACs often then use those funds to contribute to various political campaigns.
Listed below are the major contributions ($100K+) made by Pharmaceutical Research and Manufacturers of America to PACs that have contributed to current state-level elected officials, as well as all $10K+ contributions made to current state-level elected officials. Although these contributions were not made directly by Pharmaceutical Research and Manufacturers of America to the elected official, they reflect potential indirect financial ties that can also result in political influence.
Along with contributing directly to political campaigns, California’s top oligarchs and their allies make significant donations to other political action committees (PACs) that oppose various political campaigns.
Listed below are the major contributions ($100K+) made by Pharmaceutical Research and Manufacturers of America to PACs that have opposed current state-level elected officials, as well as all $10K+ contributions made in opposition to current state-level elected officials.
Although these contributions were not made directly by Pharmaceutical Research and Manufacturers of America to oppose to the elected officials, they reflect potential indirect financial influence.
Californians Against the Wrong Prescription - No on Proposition 79 Sponsored by Pharmaceutical Research and Manufacturers of America: OPPOSED: PROP 79 - PRESCRIPTION DRUG DISCOUNTS. STATE-NEGOTIATED REBATES.
$64.9 million
Californians for Affordable Prescriptions - Yes on Proposition 78 Sponsored by Pharmaceutical Research and Manufacturers of America: SUPPORTED: PROP 78 - PRESCRIPTION DRUGS. DISCOUNTS.
$56.9 million
Citizens for Paycheck Protection, Sponsored by Pharmaceutical Research and Manufacturers of America California Initiative Fund
$5.6 million
California Republican Party
$1.8 million
Californians for Jobs and a Strong Economy
$1.2 million
Keeping Californians Working, a Coalition of Insurance Agents, Technology, Energy, and Health Care Providers
$970.4k
JOBSPAC, a Bi-Partisan Coalition of California Employers
$951.7k
No on Prop 61 - Californians Against the Deceptive Rx Proposition, a Coalition of Veterans Doctors Patient Advocates Seniors Taxpayers and Members of Pharmaceutical Research and Manufacturers of America: OPPOSED: PROPOSITION 061- STATE PRESCRIPTION DRUG P
$903.3k
Democratic State Central Comm of Calif.
$835.7k
Yes on Prop. 93, a Coalition of Business, Labor, Teachers, Lawmakers, Public Safety and Assemblymembers De Leon, Nunez, Bass and Lieu: SUPPORTED: PROP 93 - LIMITS ON LEGISLATORS' TERMS IN OFFICE.
$786.5k
